Healthcare -
Biotechnology - NASDAQ - US
$ 46.52
-0.853 %
$ 1.78 B
Market Cap
-12.41
P/E
TARS - CASH & EQUIVALENTS
Cash & Equivalents TARS - Tarsus Pharmaceuticals, Inc.
225 M
LAST VALUE
14.58%
2 YEAR CAGR
148.90%
5 YEAR CAGR
0.00%
10 YEAR CAGR